Aerie Pharmaceuticals Announces Appointment of New Members of its Commercialization Team
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of David Biddell as Regional Sales Director for the Southeast Region, reporting to Gary Menichini, Aerie’s Vice President of Sales, and Shaun Gentry and Erin Horn, each as Director of National Accounts